These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28817542)

  • 1. Safety of transesophageal echocardiography‑guided electrical cardioversion in patients with atrial fibrillation and inadequate anticoagulation.
    Zaprutko J; Baszko A; Michalak M; Kochman K; Szymański R; Kłopocki J; Nowicka A; Dankowski R; Michalski M; Kałmucki P; Szyszka A
    Pol Arch Intern Med; 2017 Aug; 127(7-8):524-531. PubMed ID: 28817542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.
    Kim YG; Choi JI; Kim MN; Cho DH; Oh SK; Kook H; Park HS; Lee KN; Baek YS; Roh SY; Shim J; Park SM; Shim WJ; Kim YH
    PLoS One; 2018; 13(1):e0191648. PubMed ID: 29360845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of transesophageal echocardiography before cardioversion in atrial arrhythmias.
    Kosmalska K; Rzyman M; Miękus P; Gilis-Malinowska N; Nowak R; Fijałkowski M
    Cardiol J; 2021; 28(1):101-109. PubMed ID: 31225630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].
    Antonielli E; Pizzuti A; Gandolfo N; Bosco M; Sclavo M; Magnacca M; Leonardi G; Doronzo B; Baralis G; Di Leo M
    G Ital Cardiol; 1995 May; 25(5):543-52. PubMed ID: 7642059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS-AF Score.
    Segan L; Nanayakkara S; Spear E; Shirwaiker A; Chieng D; Prabhu S; Sugumar H; Ling LH; Kaye DM; Kalman JM; Voskoboinik A; Kistler PM
    J Am Heart Assoc; 2023 Jun; 12(12):e029259. PubMed ID: 37301743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for thrombosis and spontaneous echocardiographic contrast with sludge in atrial fibrillation patients treated with oral anticoagulants before electrical cardioversion.
    Rekosz J; Karwowski J; Kowalik I; Wiktorska A; Wrzosek K; Solecki M; Szmarowska K; Szymańska A; Mierzejewska B; Syska-Sumińska J; Dłużniewski M
    Kardiol Pol; 2024; 82(5):516-526. PubMed ID: 38606742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of left atrial thrombus by real time three-dimensional echocardiography in patients undergoing electrical cardioversion of atrial fibrillation: A contemporary cohort study.
    Bursi F; Santangelo G; Ferrante G; Massironi L; Carugo S
    Echocardiography; 2021 Apr; 38(4):518-524. PubMed ID: 33665895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
    Lurie A; Wang J; Hinnegan KJ; McIntyre WF; Belley-Côté EP; Amit G; Healey JS; Connolly SJ; Wong JA
    J Am Coll Cardiol; 2021 Jun; 77(23):2875-2886. PubMed ID: 34112315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transesophageal echocardiography-guided approach to cardioversion of atrial fibrillation.
    Leung DY; Grimm RA; Klein AL
    Prog Cardiovasc Dis; 1996; 39(1):21-32. PubMed ID: 8693093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Transesophageal Echocardiography Use, Findings, and Clinical Outcomes in the Era of Minimally Interrupted Anticoagulation for Atrial Fibrillation Ablation.
    Balouch M; Gucuk Ipek E; Chrispin J; Bajwa RJ; Zghaib T; Berger RD; Ashikaga H; Calkins H; Nazarian S; Marine JE; Spragg DD
    JACC Clin Electrophysiol; 2017 Apr; 3(4):329-336. PubMed ID: 29759444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transesophageal echocardiography-guided cardioversion of atrial fibrillation. Selection of a low-risk group for immediate cardioversion.
    Fonseca N; Caetano F; Santos J; Seixo F; Bernardino L; Silvestre I; Cardoso P; Segurado F; Inês L
    Rev Port Cardiol; 2004 Mar; 23(3):365-75. PubMed ID: 15185562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes after AF cardioversion in patients presenting left atrial sludge in trans-esophageal echocardiography.
    Squara F; Bres M; Scarlatti D; Moceri P; Ferrari E
    J Interv Card Electrophysiol; 2020 Jan; 57(1):149-156. PubMed ID: 31119494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion.
    von der Recke G; Schmidt H; Illien S; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1256-61. PubMed ID: 12411914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of left atrial thrombus in patients with atrial fibrillation: is transesophageal echocardiography necessary before cardioversion?
    Malik R; Alyeshmerni DM; Wang Z; Goldstein SA; Torguson R; Lindsay J; Waksman R; Ben-Dor I
    Cardiovasc Revasc Med; 2015; 16(1):12-4. PubMed ID: 25666720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; Morandi E; van Eickels M; Cohen A
    Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter.
    Cresti A; García-Fernández MA; Miracapillo G; Picchi A; Cesareo F; Guerrini F; Severi S
    J Am Soc Echocardiogr; 2014 Nov; 27(11):1200-7. PubMed ID: 25240491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.
    Karwowski J; Rekosz J; Mączyńska-Mazuruk R; Wiktorska A; Wrzosek K; Loska W; Szmarowska K; Solecki M; Sumińska-Syska J; Dłużniewski M
    Cardiol J; 2024; 31(3):461-471. PubMed ID: 35703043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety?
    Alyeshmerni D; Pirmohamed A; Barac A; Smirniotopoulos J; Xue E; Goldstein S; Mazel J; Lindsay J
    J Am Soc Echocardiogr; 2013 Sep; 26(9):1099-105. PubMed ID: 23850522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.